IRF3 and cancer: P53 mutants, such as R248W, R249S, R273H and R280K, have been reported to intervene cyclic GMP-AMP synthase (cGAS)-STING-TBK1-IRF3 immune cascade, resulting in immune evasion and thus promoting tumorigenesis in cancer[18].